Literature DB >> 6337094

Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.

B Kaijser, P Larsson, S Olling, R Schneerson.   

Abstract

We found that isolated Escherichia coli K13 antigen conjugated to bovine serum albumin, in contrast to isolated, non-conjugated K13, was highly immunogenic and induced protection against acute pyelonephritis caused by E. coli O6K13H1 in rats.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6337094      PMCID： PMC347916          DOI： 10.1128/iai.39.1.142-146.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  Escherichia coli K antigen.

Authors:  B Kaijser; G Vahlne
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-04

Review 2.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

3.  Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.

Authors:  B Kaijser; S Olling
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Epidemiology of symptomatic urinary tract infection in childhood.

Authors:  J Winberg; H J Andersen; T Bergström; B Jacobsson; H Larson; K Lincoln
Journal:  Acta Paediatr Scand Suppl       Date:  1974

5.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

6.  Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

Authors:  B Kaijser; P Larsson; S Olling
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

7.  Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children.

Authors:  G Lidin-Janson; E Falsen; U Jodal; B Kaijser; K Lincoln
Journal:  J Med Microbiol       Date:  1977-08       Impact factor: 2.472

8.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

9.  Protective capacity of antibodies against Escherichia coli and K antigens.

Authors:  B Kaijser; S Ahlstedt
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307
View more
  10 in total

Review 1.  Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Authors:  Ariel R Brumbaugh; Harry L T Mobley
Journal:  Expert Rev Vaccines       Date:  2012-06       Impact factor: 5.217

Review 2.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Authors:  James R Johnson; Abby Gajewski; Alan J Lesse; Thomas A Russo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Non-antibiotic prevention of urinary tract infection.

Authors:  L Hagberg; H Leffler; C Svanborg Edén
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 5.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

6.  Non-antibiotic prevention of urinary tract infection.

Authors:  L Hagberg; H Leffler; C Svanborg Edén
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

7.  Escherichia coli K5 antigen in relation to various infections and in healthy individuals.

Authors:  B Kaijser; U Jodal
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

Review 8.  Host parasite interaction in urinary tract infection.

Authors:  C Svanborg-Edén; P de Man; U Jodal; H Linder; H Lomberg
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

9.  Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

Authors:  R Schneerson; J B Robbins; C Chu; A Sutton; W Vann; J C Vickers; W T London; B Curfman; M C Hardegree; J Shiloach
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

Review 10.  Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.

Authors:  Paul Loubet; Jérémy Ranfaing; Aurélien Dinh; Catherine Dunyach-Remy; Louis Bernard; Franck Bruyère; Jean-Philippe Lavigne; Albert Sotto
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.